Neutrophil Extracellular Traps
Neutrophil extracellular traps (NETs) are web-like chromatin fibers decorated with antimicrobial histones and granule proteases extruded by activated neutrophils to ensnare and neutralize extracellular pathogens.
Neutrophil extracellular traps (NETs) are extracellular, web-like scaffolds composed of decondensed nuclear or mitochondrial chromatin DNA studded with histones, neutrophil elastase, myeloperoxidase (MPO), and antimicrobial peptides released by activated neutrophils to immobilize and kill bacteria, fungi, and protozoa in tissues and the bloodstream. First described by Volker Brinkmann, Arturo Zychlinsky, and colleagues in Science in 2004, NET formation (NETosis) represents a dramatic third antimicrobial effector mechanism alongside phagocytosis and degranulation—acting as an extracellular sticky net that prevents pathogen dissemination when microbes are too large to engulf individually, such as fungal hyphae.
Molecular Cascade of Suicidal and Vital NETosis
Classical (suicidal) NETosis unfolds over 2 to 4 hours following neutrophil stimulation by lipopolysaccharide (LPS), phorbol esters, Staphylococcus aureus, or immune complexes:
- Reactive oxygen species (ROS) burst: Activation of NADPH oxidase (NOX2) generates superoxide and hydrogen peroxide, triggering MPO-dependent release of neutrophil elastase (NE) from azurophilic granules into the cytosol and nucleus.
- Chromatin decondensation: Inside the nucleus, neutrophil elastase cleaves linker histones while peptidylarginine deiminase 4 (PAD4) citrullinates arginine residues on histones H3 and H4, neutralizing positive charges so tightly wound chromatin unspools.
- Nuclear envelope breakdown and extrusion: The nuclear membrane disintegrates, mixing decondensed DNA with cytoplasmic and granular antimicrobial proteins before plasma membrane rupture (mediated partly by gasdermin D pores) expels the sticky chromatin web into the extracellular space.
In contrast, vital NETosis—triggered rapidly within minutes via Toll-like receptor and complement signaling—packages chromatin-filled vesicles that exocytose without immediate plasma-membrane lysis, leaving an anucleate cytoplast still capable of chemotaxis and phagocytosis.
Antimicrobial Function and Microbial Evasion
Once deployed, NETs trap microbes physically within sticky DNA lattices while exposing them to lethal local concentrations of histones (potent cationic membrane disruptors), myeloperoxidase-generated hypochlorous acid, and serine proteases. In response, successful bacterial pathogens have evolved specialized countermeasures: Streptococcus pyogenes and Staphylococcus aureus secrete extracellular DNases (nucleases) that digest the DNA backbone to escape NET entrapment, while encapsulated bacteria use negatively charged polysaccharide capsules to repel electrostatic binding.
Immunopathology: Thrombosis, Sepsis, and Autoimmunity
Although protective during acute infection, dysregulated or excessive NET release—or impaired clearance by host plasma DNase I—inflicts severe collateral tissue damage ("immunothrombosis"):
- Vascular thrombosis: Negatively charged DNA and histones activate Factor XII, trap platelets, and anchor fibrin clots inside microvessels during sepsis and COVID-19 ARDS.
- Autoimmune exposure: Exposing citrullinated histones, double-stranded DNA, and MPO externally provides self-antigens that drive autoantibody production in systemic lupus erythematosus (SLE), rheumatoid arthritis, and ANCA-associated vasculitis.
Frequently Asked Questions
What are neutrophil extracellular traps made of? They consist primarily of decondensed chromatin DNA fibers coated with antimicrobial histones and neutrophil granule enzymes such as neutrophil elastase and myeloperoxidase.
Are NETs always beneficial to the host? No. While they trap bacteria and large fungal hyphae, excessive NETs inside blood vessels promote microthrombosis, acute lung injury, and autoimmune diseases such as lupus.
Regulation, Clearance, and Pathological Consequences
Timely clearance of neutrophil extracellular traps (NETs) is essential to prevent chronic tissue injury once invading pathogens are neutralized. Endogenous deoxyribonucleases, primarily serum DNase I and macrophage-derived DNase1L3, digest the extracellular chromatin scaffold into soluble fragments that tissue-resident macrophages subsequently clear by phagocytosis.
NETosis in Autoimmunity and Immunothrombosis
When NET formation outpaces enzymatic clearance, exposed nuclear antigens—including double-stranded DNA, citrullinated histones, and myeloperoxidase—stimulate autoreactive B cells and plasmacytoid dendritic cells, driving flare cycles in systemic lupus erythematosus and rheumatoid arthritis. Furthermore, negatively charged DNA strands and neutrophil elastase within vascular NETs activate Factor XII, cleave tissue factor pathway inhibitor, and trap platelets, promoting microvascular immunothrombosis during severe sepsis, acute respiratory distress syndrome, and viral pneumonia.
Signaling Cascades: Suicidal Versus Vital NETosis
Laboratory studies distinguish two principal pathways of NET release. In classical suicidal NETosis, phorbol esters or microbial ligands activate NADPH oxidase to generate reactive oxygen species, triggering nuclear envelope disintegration and chromatin decondensation via peptidylarginine deiminase 4 (PAD4) citrullination over two to four hours. By contrast, vital NETosis occurs within minutes upon Toll-like receptor engagement, vesicularizing nuclear DNA for exocytosis while leaving the anucleate neutrophil cytoplast capable of continued chemotaxis and phagocytosis.
Experimental Quantification and Clinical Biomarkers
Researchers quantify circulating NET remnants in plasma using sandwich enzyme-linked immunosorbent assays targeting myeloperoxidase-DNA complexes, nucleosomes, and citrullinated histone H3 (CitH3), alongside fluorescence microscopy with membrane-impermeable DNA dyes such as SYTOX Green. Elevated plasma CitH3 and cell-free DNA concentrations correlate with organ dysfunction scores in hospitalized sepsis cohorts and are under active investigation as prognostic biomarkers and therapeutic targets for recombinant DNase inhalation or PAD4 inhibition.
References
- Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D. S., Weinrauch, Y., & Zychlinsky, A. (2004). Neutrophil Extracellular Traps Kill Bacteria. Science, 303(5663), 1532–1535. https://doi.org/10.1126/science.1092385
- Openshaw, P. (2004). Faculty Opinions recommendation of Neutrophil Extracellular Traps Kill Bacteria. Faculty Opinions. https://doi.org/10.3410/f.1017763.210419
- Deretic, V. (2004). Faculty Opinions recommendation of Neutrophil Extracellular Traps Kill Bacteria. Faculty Opinions. https://doi.org/10.3410/f.1017763.206661